CASP1 and stroke disorder: Furthermore, in spleens of animals treated with 4-sulfonic calix[6]arene there was less caspase-1 activation post-stroke, determined by western blotting for cleaved caspase-1 (Figures 5G and 5H) and by FLICA (Figure 5I), suggesting an inhibition of inflammasome activation.